ForteBio is a Menlo Park, Calif. company that makes instruments for biomolecular analysis in the life sciences. Its instruments can measure proteins, DNA, RNA and other small molecules without the use of labels.
Label-free measurement dispenses with the chemical markers that most techniques use, allowing for faster and cheaper analysis.
The company took $25 million from OrbiMed Advisors, MPM Capital, Alloy Ventures, Latterell Venture Partners, Versant Ventures and Vertical Group. This was ForteBio’s third funding; in its previous round,it took $17.3 million.
Next Story: Stayin' alive: Roku to open its box
Previous Story: Gmail hits 7 gigabytes of storage
Tags: deal
